Price $69.91 |
Market Cap
9.06B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
14.1
|
P/B
2.51
|
P/S
0.71
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
14.2
|
Op. Cash Flow
737.9K
|
FCF
4.6
|
|
Op. Margin
6.90%
|
Net Margin
5.10%
|
ROE
18.50%
|
ROI
15.20%
|
|
ROA
7.70%
|
EPS Growth
10.30%
|
Current Ratio
1.7
|
Debt/Equity
23.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Invacare Corporation (IVC) | $0.80 | - | - | 29.8M | Strong Buy |
| China SXT Pharmaceuticals Inc (SXTC) | $0.81 | - | - | 2.9M | Strong Buy |
| Chromadex Corp (CDXC) | $1.36 | - | - | 85.4M | Strong Buy |
| Invo Bioscience Inc (INVO) | $1.33 | - | - | 13.8M | Strong Buy |
| CordovaCann Corp (LVRLF) | $0.17 | - | - | 17M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
